Details of the Drug Reposition

General Information of This Drug (ID: DMNDH3J)

• Drug Name: Oraxol (DMNDH3J)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastric adenocarcinoma	DISWWLTC	2B72	Phase 3	[1]
Breast cancer	DIS7DPX1	2C60-2C65	Phase 3	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)